Secure AI is a clinical responsibility

Secure AI is not a feature badge. In behavioral health it is how you protect trust when tools touch notes, intakes, and the hard things people only say in session.

AI is moving into behavioral health whether practices are ready or not. Some tools arrive through approved vendors. Others slip in through browser tabs, copied notes, intake summaries, and "just this once" shortcuts that become workflow.

That matters because behavioral health data is not ordinary data. It carries diagnoses, trauma histories, substance use details, family systems, medications, safety plans, and disclosures people may never have shared anywhere else. If AI touches that environment, "secure" cannot mean a logo on a sales page. It has to mean governance, safeguards, accountability, and clinical context from the start.

2026 is making the compliance floor more concrete. Updated enforcement around 42 CFR Part 2 sharpened attention on how substance use records are handled and segmented. OCR continues to focus on real HIPAA risk analysis and the operational controls that protect ePHI. AI belongs inside that risk conversation.

A serious AI risk analysis asks uncomfortable questions:

1) What AI tools are staff actually using?

2) Is PHI landing in systems that are not approved?

3) Do vendors sign Business Associate Agreements when required?

4) Are prompts, outputs, and uploads retained or used for model training?

5) Can the practice audit access and activity?

6) Are Part 2 records handled differently where required?

7) Who owns the decision when AI output is wrong?

That is not bureaucracy for its own sake. It is the difference between a helpful tool and an unmanaged disclosure pathway.

Encryption and access controls matter. So do least-privilege APIs, audit logs you can actually use, explicit prompt retention rules, and BAAs when a vendor creates, receives, maintains, or transmits PHI. A flashy model with none of that does not belong near a chart.

Part 2 changes the design problem. "Available in the chart" does not always mean "appropriate for this use." Consent-aware segmentation is part of safe AI design, not a nice-to-have.

Most practices do not adopt risky AI because they are reckless. They do it because people are tired. The better path is not "ban everything" or "figure it out alone." Make responsible use easier than improvisation: inventory tools, define what never goes into public AI, put AI inside the risk analysis, train on real examples, and review before new tools touch PHI.

At EMILE-E this is the work we care about: technology that protects trust instead of putting it at risk. Secure AI is not about slowing innovation down. It is about making sure innovation is worthy of the room it is entering.

If you want the longer cut, Issue 002 ("Secure AI Is Not a Feature. It Is a Clinical Responsibility.") lives on our site. This weekly note is the short form.

Learn more about EMILE-E Practice OS: https://www.emile-e.tech/practice-os

(Practice OS: $89 per clinician / month. Optional white-glove data migration $2,500; self-serve free.)

Until next time. The work matters. Trust is the product.